CONDENSED ABSTRACT
Sudden cardiac death (SCD) is the primary driver of mortality in patients with end-stage renal disease (ESRD). Historically, SCD has been assumed to be due to fatal ventricular arrhythmias (VAs), but recent data has suggested bradyarrhythmias and asystole may actually play a larger role than previously suspected. We compared cardiac implantable electronic device (CIED) interrogation data in ESRD and non-ESRD patients and found no differences in VA burden between groups. Additionally, control patients were more likely to require device therapies. Thus, VA events may play a smaller role in SCD in ESRD patients than previously assumed.